Corporate Influence on Science and Regulation – III

Abstract

The influence of corporate interests – most notably from the cigarette, chemical, pharmaceutical, and food industries – on science and on health and environmental regulation has attracted a growing media and public attention. STS research has explored this issue in different ways, for example through the analysis of the impact of industry-funding on scientific publications, the study of corporate-biases in the production regulatory standards, or more broadly by questioning the commercialization of science. This panel brings together researchers taking on board the question of corporate influence on science and public regulation. This session will focus on the regulation, regulatory spaces and actors, of corporate influence.

Individual Presentations

• Ignoring by Denouncing Corporate Influence - françois dedieu, National Institute for Agricultural research

• Who’s Running Plant Genetic Improvement in France: Overlapping Interests of Trade and Politics - Aïcha Bourad, INRA UMR AGIR

• Regulatory Intermediaries in Commercially-Driven Prenatal Screening - Kelly Holloway, University of Toronto; Fiona A. Miller, University of Toronto; Nicole Simms, University of Toronto

• Influencing « Policy Options » at the OECD: The Promotion of Value-Based Pricing by Pharmaceutical Companies - Pierre-André Juven, CNRS

Session Organizer

• Henri Boullier, INRA - IRISSO, Université Paris-Dauphine